Evaluating Critical Asset Safeguards for Pharmaceutical Manufacturers

evaluating-critical-asset-safeguards-for-pharmaceutical (1)

Pharmaceutical and Biotechnology companies create products that generate billions of dollars in annual sales. As product demand and manufacturing outputs increase for these products, so do the demands for trouble free manufacturing equipment, performance and reliability requirements. One central issue for these companies’ supply chains is the lack of an effective risk management process for readily identifying the potential for equipment performance issues or breakdowns. The absence of such a process creates a major imperative for these companies

GenesisSolutions, the Asset Management service line of ABS Group, launched an initiative to address risk and equipment reliability issues that may affect the products manufactured by a global pharmaceutical company. A risk management solution was developed to standardize an approach to addressing specific products across the company’s multiple facilities.

Download Evaluating Critical Asset Safeguards for Pharmaceutical Manufacturers Whitepaper

Red Hat may use your personal data to inform you about its products, services, and events.
You can stop receiving marketing emails by clicking the unsubscribe link in each email or withdraw your consent at any time in the preference center. See Privacy Statement for details.



more posts

send us a message